擦试不掉
发表于 2025-3-23 11:14:35
http://reply.papertrans.cn/29/2813/281259/281259_11.png
Orchiectomy
发表于 2025-3-23 14:28:59
http://reply.papertrans.cn/29/2813/281259/281259_12.png
RODE
发表于 2025-3-23 19:12:16
http://reply.papertrans.cn/29/2813/281259/281259_13.png
Haphazard
发表于 2025-3-23 22:22:50
http://reply.papertrans.cn/29/2813/281259/281259_14.png
ATRIA
发表于 2025-3-24 03:28:08
Treatment of Recurrent Hepatitis C,e the natural history of recurrent hepatitis. Preliminary studies indicate that approximately 90 % of people with recurrent HCV could be cured with a combination of direct acting antiviral drugs with minimal side effects.
fertilizer
发表于 2025-3-24 08:52:59
http://reply.papertrans.cn/29/2813/281259/281259_16.png
颠簸下上
发表于 2025-3-24 12:01:43
Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation,s are limited for recurrent PSC. For these important entities affecting PSC patients after liver transplantation, we review the current published data on epidemiology, diagnostic criteria, risk factors, graft and patient survival, and treatment of recurrent PSC.
千篇一律
发表于 2025-3-24 17:21:01
http://reply.papertrans.cn/29/2813/281259/281259_18.png
盘旋
发表于 2025-3-24 19:51:58
Recurrence of HCC When Transplanted Outside Milan Criteria,r LT. The main disadvantage of this set of criteria is that it is relatively restrictive. Several attempts have been made to expand these criteria to include tumors of greater number and size. The model for end-stage liver disease (MELD) prioritization system has utilized the Milan criteria since ad
Acupressure
发表于 2025-3-24 23:09:01
Role of Neoadjuvant and Adjuvant Treatment in HCC Recurrence After Liver Transplantation, the Milan criteria have been shown to be 8–15 % and higher in those patients beyond the Milan criteria. The value of adjuvant therapy using systemic cytotoxic chemotherapy after LT has been disappointing. Sorafenib has been used for treatment in recurrent HCC after LT, and the data of safety and ef